abstract |
Disclosed are compounds having enhanced potency in modulating the activity of the NMDA receptor. Such compounds may be used in the treatment of pathologies such as depression and related disorders. Also disclosed are other pharmaceutically acceptable delivery forms of compounds, including orally administrable formulations and intravenous formulations. |